swingingtech Posted - 2 months ago

$BIIB $ESALY $NVS $GENENTECH https://wallstreetwaves.com/biogen-could-engage-in-1b-2b-deals-to-fill-revenue-shortfall-gaps-analyst-says/

DonCorleone77 Posted - 3 months ago

$BIIB $ESALY Biogen, Eisai report Leqembi approved in China for Alzheimer's treatment Eisai Co. (ESALY) and Biogen (BIIB) announced that humanized anti- soluble aggregated amyloid-beta monoclonal antibody "LEQEMBI" has been approved in China as a treatment of mild cognitive impairment due to Alzheimer's disease and mild AD dementia. Preparations for launch within the second quarter of Eisai's FY 2024, July 1 - September 30, 2024, are underway, the companies stated.

TrendyChart Posted - 6 months ago

Upcoming Earnings Report: $ESALY Eisai Co Ltd ADR will be reporting on 11/06/2023 at 3:00AM | Will earnings surpass or fall short of projections?

hurleyburly Posted - 7 months ago

@HWtrying not so sure it's a two way race between $LLY and $ESALY anymore. Check out this story from last night's news on Alzheimers and NKGEN who is going public thru $GFOR https://pix11.com/video/experimental-alzheimers-treatments-showing-promise/8997554/

TangoToEvora Posted - 9 months ago

$ESALY wow, what happened. +300%?

money01 Posted - 9 months ago

$ESALY no movement on this one?

money01 Posted - 9 months ago

$ESALY $BIIB seems to be reaping the benefits of Lecanemab...

money01 Posted - 9 months ago

$ESALY even better breakdown from Zack Bristow at seeking alpha. ...."The medication costs ~$26,500 annually, meaning patients would be forking out a maximum of $5,300 per year [at 80% reimbursement, or $441 per month] if not 100% covered"

money01 Posted - 9 months ago

$ESALY administered thru biweekly infusions ....there are 26 ( bi weeks/ yr ) so costs $1000/ mo. ...factor in insurance & medicare coverage....me thinks it's affordable to keep Grandma & Pa sharp. 😆

Lanai_Chris Posted - 9 months ago

$ESALY google the details of the drug. It’s >$26k a year. Most people won’t have the resources to spend that amount on a prescription. 😢

money01 Posted - 9 months ago

$ESALY need to see some sales numbers...

MOONPYE2008 Posted - 9 months ago

$ESALY is anyone buying this? Curious that

money01 Posted - 9 months ago

$ESALY do they have any sales numbers yet?

Fast_Eddie_Felson Posted - 9 months ago

$ESALY is this even going to move tomorrow or is BIIB going to see the action? Price action here is horrendous

DonCorleone77 Posted - 9 months ago

$BIIB $ESALY Biogen, Eisai win full FDA approval for Alzheimer's drug Leqembi The Food and Drug Administration converted Biogen (BIIB) and Eisai's (ESALY) Leqembi, indicated to treat adult patients with Alzheimer's Disease, to traditional approval following a determination that a confirmatory trial verified clinical benefit. Leqembi is the first amyloid beta-directed antibody to be converted from an accelerated approval to a traditional approval for the treatment of Alzheimer's disease, the agency said in a statement. The drug works by reducing amyloid plaques that form in the brain, a defining pathophysiological feature of the disease, it added. Leqembi was approved in January under the accelerated approval pathway.

marginalb Posted - 9 months ago

$BIIB $ESALY which one to buy ?

marginalb Posted - 9 months ago

$ESALY is this the approval $SPY ?

moneybags4ever Posted - 9 months ago

$ESALY why does this company have two different ticker symbols..: ESAIY.. idk which one to buy

STCKPRO Posted - 9 months ago

$ESALY NEW ARTICLE : Catalyst Pharmaceuticals: Cheap For A Reason https://www.stck.pro/news/ESALY/54880137/

GeoWhite Posted - 10 months ago

$ESALY

HIA14 Posted - 10 months ago

$LXEH Looking positively for next week. Watch $ESALY they got FDA Approval!

Austero Posted - 10 months ago

$CUBT CEO P. Michaels setting up to leverage extensive Japanese network in Pharma. $TAK $ALPMY $ESALY

EarningsInsider Posted - 11 months ago

$ESALY updates FY 2024 guidance to $1.02-$1.02 EPS and revenue guidance to $5.48 billion-$5.48 billion. www.marketbeat.com/stocks/OTCMKTS/E

MarketBeat Posted - 11 months ago

Eisai upgraded by Citigroup Inc. to buy. www.marketbeat.com/stocks/OTCMKTS/ESALY/price-target/ $ESALY

STCKPRO Posted - 11 months ago

$ESALY NEW ARTICLE : Advanced Infusion Care (AIC) now offers Eisai infusion therapy LEQEMBI™ (Lecanemab-irmb) humanized immunoglobulin gamma 1 (IgG1) monoclonal antibody https://www.stck.pro/news/ESALY/50960945/

MarketBeat Posted - 11 months ago

Eisai initiated by Sanford C. Bernstein at outperform. www.marketbeat.com/stocks/OTCMKTS/ESALY/price-target/ $ESALY

Limey42 Posted - 1 year ago

$ESALY https://www.dailymail.co.uk/health/article-12028605/Why-makers-Alzheimers-wonder-drug-silent-effects.html

FE123 Posted - 1 year ago

$ESALY Bad News For Eisai But Great News for $IOVA!

STCKPRO Posted - 1 year ago

$ESALY NEW ARTICLE : Merck and Eisai report disappointing results from trials of combination treatment for melanoma and colorectal cancer https://www.stck.pro/news/ESALY/46705563

italian_shoemaker Posted - 1 year ago

$ESALY Whats going on with the price here $65? Everywhere it is still $14.